Peptide therapy TikTok claims: what the science actually supports

What did @cleaneve actually say?

After slamming her finger in a car door and getting an urgent care x-ray confirming no fracture, @cleaneve credits her recovery to two peptides she was already taking for a knee injury: oral BPC-157 and injectable TB-500. She estimates the swelling is "45% better" the next day and closes with a bold prediction: "This is going to put orthos out of business." She's on day 12 of her peptide protocol and frames the rapid improvement as proof the peptides are working systemically, not just locally. To her credit, she does note she was already using them before the finger injury, which is at least honest about the context. But attributing 24-hour swelling reduction primarily to a peptide protocol, rather than ice, rest, or the body's normal acute inflammatory response, is a significant leap.

Does the science back this up?

Partially, but not in the way the video implies. BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from human gastric juice. Animal studies have shown accelerated tendon-to-bone healing and reduction in inflammation. A frequently cited study by Sikiric et al. (2018, Current Pharmaceutical Design) found BPC-157 promoted angiogenesis and tissue repair in rodent models of soft tissue injury. TB-500 is a synthetic version of Thymosin Beta-4. Chang et al. (2011, Annals of the New York Academy of Sciences) documented its role in actin regulation and wound repair in animal studies. The problem: nearly all of this evidence is preclinical. There are no published randomized controlled trials in humans confirming that either peptide accelerates recovery from acute blunt trauma like a crushed finger. Extrapolating from rat tendon studies to human finger smashed in a car door is a stretch the data does not currently support.

What did they get wrong (or right)?

Let's be fair. She got a few things right. TB-500 does have documented effects on muscle and ligament repair in animal models, so her description of its mechanism as helping "repair muscles and ligaments and bring circulation" is a reasonable lay summary of what the preclinical literature suggests. She also did not claim the finger was broken and then healed, which would have been far more irresponsible. What she got wrong, or at least dramatically oversimplified: a finger slammed in a car door with no fracture, significant swelling, and then 24-hour improvement is extremely consistent with normal acute injury resolution. The inflammatory response peaks within hours and begins resolving within one to two days for minor soft tissue injuries. This is textbook physiology, not peptide magic. Attributing that resolution to TB-500 without any control comparison is classic post hoc reasoning. The "healing crisis" she describes feeling in her knee after injection is also not a validated clinical phenomenon, and leaning into that framing can encourage people to interpret side effects as progress.

What should you actually know?

Both BPC-157 and TB-500 exist in a regulatory gray zone. Neither is FDA-approved for human therapeutic use. They are available through compounding pharmacies and research chemical suppliers, but the quality control and dosing consistency of those sources varies widely. The FDA has previously issued warning letters regarding BPC-157 compounded products. If you are considering either peptide, that needs to happen through a licensed provider who can assess your specific situation, not a TikTok protocol. The "proof is in the pudding" logic here is genuinely dangerous framing. A single anecdote about a non-fractured finger recovering overnight tells us almost nothing about whether these compounds work, and it could convince someone to self-inject an unvetted compound based on a thumbnail. The existing animal literature is legitimately interesting. The human clinical evidence is not there yet. Those are two very different things.

Should you worry about the "puts orthos out of business" claim?

Yes, flag this one. Claiming a peptide protocol will replace orthopedic medicine is the kind of hyperbole that gets people hurt. Orthopedic surgeons treat fractures, ligament ruptures, joint degeneration, and surgical complications. There is no credible evidence that any peptide currently available replaces those interventions. For someone watching this video who has a serious musculoskeletal injury and decides to skip medical evaluation in favor of a peptide stack, that delay could have real consequences. Minor soft tissue injuries often do resolve on their own with or without peptides. Serious ones do not, and the window for some surgical interventions is time-sensitive. The excitement about peptides is understandable given the animal data, but responsible use starts with getting an actual diagnosis first.